KJ Mayne

Statistics

Publications

Citations

198

H-Index

Active since

2023

Affiliations

University of Oxford(Current)

KJ Mayne is an author at University of Oxford specializing in renal disease, chronic kidney disease progression prevention, and chronic kidney disease.

Publications per year

2023–2023

Publications

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–2 of 2